We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Edited by
Deepak Cyril D'Souza, Staff Psychiatrist, VA Connecticut Healthcare System; Professor of Psychiatry, Yale University School of Medicine,David Castle, University of Tasmania, Australia,Sir Robin Murray, Honorary Consultant Psychiatrist, Psychosis Service at the South London and Maudsley NHS Trust; Professor of Psychiatric Research at the Institute of Psychiatry
Abrupt cessation of chronic and frequent cannabis use is associated with cannabis withdrawal. Cannabis withdrawal syndrome is a clinically significant diagnosis and a criterion of cannabis use disorder (CUD) marked by mood and sleep disturbance symptoms, appetite and/or weight loss and restlessness, and physical symptoms such as abdominal pain, shakiness/tremors, sweating, fever, chills and headaches. The goal of this chapter is to fully characterize the clinical significance, time course, neurological mechanisms and treatment of cannabis withdrawal. The chapter synthesizes studies examining individual difference factors (demographics, cannabis use patterns, genetics and heritability and psychiatric comorbidity) that place some people at disproportionally higher risk for cannabis withdrawal or greater severity of symptoms. The cyclical nature of resuming use due to the inability to cope with the distress of cannabis withdrawal is negatively reinforcing and presents major challenges to individuals trying to abstain from problematic cannabis use. Implications for evidence-based strategies that can help mitigate the psychological and physiological symptoms of cannabis withdrawal are discussed.
Endogenous cannabinoids assist in regulation of hunger, pain perception, inflammation, and stress responses. Tetrahydrocannabinol (THC), a component of cannabis, activates cannabinoid receptors, producing effects that are often emotionally pleasing and cognitively interesting. THC effects impair complex tasks, such as driving. Addiction develops in 8--10 percent of all cannabis users, and in about 25 percent of daily users. Regular adolescent users are especially vulnerable. Adverse outcomes of cannabis addiction include too much time spent intoxicated, important activities given up, worsening of psychological problems, and failed attempts to stop use. The withdrawal syndrome includes irritability, anxiety, depression, and sleep difficulties. Long-term heavy use of cannabis is associated with academic failure and subtle cognitive impairment. Medical uses of cannabis include relief of nausea, appetite improvement, and lessened neuropathic pain. Medical use may increase cannabis addiction, a risk somewhat similar to that of other, more traditional medications for pain, anxiety, and attention disorders. Because cannabis is now a commercial product, its potency has increased in recent years.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.